Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvie in Type 2 Diabetes with Inadequate Control on Metformin and DPP-4 Inhibitor
NCT03770052Phase 4Completed
- Sponsor
- Pusan National University Hospital
- Start
- Oct 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lobeglitazone in type 2 diabetes mellitus (T2DM), sponsored by Pusan National University Hospital. Started Oct 2018; status: completed.
02
Drugs
lobeglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03770052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770052.